Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2024-04-08 Management Reports
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management's Discussion and Analysis for the year ended December 31, 2023' and contains detailed discussion of the company's business operations, product focus, market strategy, forward-looking statements, and financial context. It references the audited consolidated financial statements for the year ended December 31, 2023, and the annual report on Form 20-F for the same period. The content is consistent with a Management Discussion and Analysis (MD&A) section typically found in annual or interim reports, providing substantive financial and operational analysis rather than just an announcement or summary. The length of the document (15,000 characters) and the detailed nature of the discussion confirm it is a full report rather than a brief announcement or certification. Therefore, the document should be classified as a Management Reports (MDA) filing type.
2024-04-08 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2023. The document explicitly states it is a certification and does not contain actual financial statements or detailed financial data. It is primarily an officer certification letter related to annual filings, not the filings themselves. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports.
2024-04-08 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2023. The document is a certification letter and does not contain actual financial data or the full annual report itself. It explicitly states it is a certification and notes differences from non-venture issuer certifications. Given the document's nature as an officer certification related to annual filings, it falls under Regulatory Filings (RNS) according to the Certification Rule, which states that certifications should be classified as RNS rather than the report they reference. The document length is short (3126 characters), consistent with a certification letter rather than a full report.
2024-04-08 English
News release - English.pdf
Earnings Release Classification · 85% confidence The document is a press release announcing a conference call to present the company's 2023 year-end financial results scheduled for April 9, 2024. It states that the financial results will be filed after April 8, 2024, but does not contain the actual financial results or detailed financial statements. The document includes call details and a forward-looking statement disclaimer, typical of earnings release announcements. It is not the earnings release itself but an announcement of the upcoming earnings call and results presentation. Therefore, the document fits best as a Call Transcript (CT) category since it is about a conference call for financial results presentation, but since it is only announcing the call and not the transcript, it is more appropriate to classify it as an Earnings Release (ER) because it announces the initial financial results presentation. However, since it does not contain the actual financial results but only announces the call, the best fit is Earnings Release (ER) with moderate confidence. FY 2023
2024-04-05 English
News release - English.pdf
Regulatory Filings
2023-12-06 English
News release - English.pdf
Regulatory Filings
2023-11-23 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.